Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy

被引：24

作者：

Narahira, Atsushi ^{[1
]}

Yanagi, Teruki ^{[1
]}

Cho, Kyu Yong ^{[2
]}

Nakamura, Akinobu ^{[2
]}

Miyoshi, Hideaki ^{[2
]}

Hata, Hiroo ^{[1
]}

Imafuku, Keisuke ^{[1
]}

Kitamura, Shinya ^{[1
]}

Shimizu, Hiroshi ^{[1
]}

机构：

[1] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan

[2] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan

来源：

JOURNAL OF DERMATOLOGY | 2017年 / 44卷 / 04期

关键词：

MELANOMA; ANTI-CTLA-4;

D O I：

10.1111/1346-8138.13571

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100227 [皮肤病学];

摘要：

引用

页码：E70 / E70

页数：1

共 5 条

[1]

Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes [J].

Freeman-Keller, Morganna ;

Kim, Youngchul ;

Cronin, Heather ;

Richards, Allison ;

Gibney, Geoffrey ;

Weber, Jeffrey S. .

CLINICAL CANCER RESEARCH, 2016, 22 (04) :886-894

[2]

Neurological symptoms in a patient with isolated adrenocorticotropin deficiency: case report and literature review [J].

Goto, Yukihiro ;

Tatsuzawa, Kazunori ;

Aita, Kazuyasu ;

Furuno, Yuichi ;

Kawabe, Takuya ;

Ohwada, Kei ;

Sasajima, Hiroyasu ;

Mineura, Katsuyoshi .

BMC ENDOCRINE DISORDERS, 2016, 16

[3]

Kähler KC, 2016, J DTSCH DERMATOL GES, V14, P662, DOI [10.1111/ddg.13047, 10.1111/ddg.13047_g]

[4]

Nivolumab in Previously Untreated Melanoma without BRAF Mutation [J].

Robert, Caroline ;

Long, Georgina V. ;

Brady, Benjamin ;

Dutriaux, Caroline ;

Maio, Michele ;

Mortier, Laurent ;

Hassel, Jessica C. ;

Rutkowski, Piotr ;

McNeil, Catriona ;

Kalinka-Warzocha, Ewa ;

Savage, Kerry J. ;

Hernberg, Micaela M. ;

Lebbe, Celeste ;

Charles, Julie ;

Mihalcioiu, Catalin ;

Chiarion-Sileni, Vanna ;

Mauch, Cornelia ;

Cognetti, Francesco ;

Arance, Ana ;

Schmidt, Henrik ;

Schadendorf, Dirk ;

Gogas, Helen ;

Lundgren-Eriksson, Lotta ;

Horak, Christine ;

Sharkey, Brian ;

Waxman, Ian M. ;

Atkinson, Victoria ;

Ascierto, Paolo A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :320-330

[5]

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial [J].

Weber, Jeffrey S. ;

D'Angelo, Sandra P. ;

Minor, David ;

Hodi, F. Stephen ;

Gutzmer, Ralf ;

Neyns, Bart ;

Hoeller, Christoph ;

Khushalani, Nikhil I. ;

Miller, Wilson H., Jr. ;

Lao, Christopher D. ;

Linette, Gerald P. ;

Thomas, Luc ;

Lorigan, Paul ;

Grossmann, Kenneth F. ;

Hassel, Jessica C. ;

Maio, Michele ;

Sznol, Mario ;

Ascierto, Paolo A. ;

Mohr, Peter ;

Chmielowski, Bartosz ;

Bryce, Alan ;

Svane, Inge M. ;

Grob, Jean-Jacques ;

Krackhardt, Angela M. ;

Horak, Christine ;

Lambert, Alexandre ;

Yang, Arvin S. ;

Larkin, James .

LANCET ONCOLOGY, 2015, 16 (04) :375-384

← 1 →